These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7579555)

  • 1. Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapy: a randomized trial.
    Adams M; Soukop M; Barley V; Yosef H; Anderson H; Boesen E; Trask CW; Rüfenacht E; de Bruijn KM
    Anticancer Drugs; 1995 Aug; 6(4):514-21. PubMed ID: 7579555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open multicentre study of tropisetron for cisplatin-induced nausea and vomiting.
    Olver IN; Craft PS; Clingan PR; Kearsley JH; Planner RS; van Hazel GA; Bell DR; Adena MR; Hall BE; Pearson LL
    Med J Aust; 1996 Mar; 164(6):337-40. PubMed ID: 8606657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy.
    Sorbe B; Högberg T; Himmelmann A; Schmidt M; Räisänen I; Stockmeyer M; de Bruijn KM
    Eur J Cancer; 1994; 30A(5):629-34. PubMed ID: 8080678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of efficacy and tolerability of tropisetron in the prevention of cisplatin induced nausea and vomiting.
    Chiersilpa A; Ngow J
    J Med Assoc Thai; 1999 Sep; 82(9):915-21. PubMed ID: 10561949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
    Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study.
    Chua DT; Sham JS; Kwong DL; Kwok CC; Yue A; Foo YC; Chan R
    Am J Clin Oncol; 2000 Apr; 23(2):185-91. PubMed ID: 10776982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis.
    Garcia-del-Muro X; Vadell C; Pérez Manga G; Bover I; Rifá J; Beltrán M; Barros MM; Germá JR; Fabregat X; Moreno V; Salvador A; Viladiu P
    Eur J Cancer; 1998 Jan; 34(1):193-5. PubMed ID: 9624257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.
    Hulstaert F; Van Belle S; Bleiberg H; Canon JL; Dewitte M; Buyse M; De Keyser P; Westelinck KJ
    J Clin Oncol; 1994 Nov; 12(11):2439-46. PubMed ID: 7964961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
    Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.
    Van Belle SJ; Cocquyt VF; Bleiberg H; Canon JL; Buyse M; Hulstaert F; De Witte M; De Keyser P; Westelinck K
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():22-30. PubMed ID: 7749166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    Malik I; Moid I; Khan Z; Hussain M
    Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiemetic efficacy of tropisetron plus dexamethasone as compared with conventional metoclopramide-dexamethasone combination in Orientals receiving cisplatin chemotherapy: a randomized crossover trial.
    Chua DT; Sham JS; Au GK; Choy D; Kwong DL; Yau CC; Cheng AC
    Br J Clin Pharmacol; 1996 May; 41(5):403-8. PubMed ID: 8735681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-emetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation.
    Barbounis V; Koumakis G; Hatzichristou H; Vassilomanolakis M; Tsoussis S; Efremidis A
    Support Care Cancer; 1999 Mar; 7(2):79-83. PubMed ID: 10089087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy.
    Herrstedt J; Sigsgaard TC; Nielsen HA; Handberg J; Langer SW; Ottesen S; Dombernowsky P
    Support Care Cancer; 2007 Apr; 15(4):417-26. PubMed ID: 17093916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin.
    Schmidt M; Sorbe B; Högberg T; Himmelmann A; Räisänen I; Stockmeyer M; de Bruijn KM
    Ann Oncol; 1993; 4 Suppl 3():31-4. PubMed ID: 8363997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.